Bcl-B: an "unknown" protein of the Bcl-2 family.

Bcl-2 family proteins Bcl-B/Bcl-2L10 Carcinogenesis Embryogenesis Oogenesis Programmed cell death

Journal

Biology direct
ISSN: 1745-6150
Titre abrégé: Biol Direct
Pays: England
ID NLM: 101258412

Informations de publication

Date de publication:
30 10 2023
Historique:
received: 19 10 2023
accepted: 23 10 2023
medline: 31 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: epublish

Résumé

Bcl-B is a poorly understood protein of the Bcl-2 family that is highly expressed in many healthy tissues and tumor types. Bcl-B is considered an antiapoptotic protein, but many reports have revealed its contradictory roles in different cancer types. In this mini-review, we elucidate the functions of Bcl-B in normal conditions and various pathologies, its regulation of programmed cell death, its oncogene/oncosuppressor activity in tumorigenesis, its impact on drug-acquired resistance, and possible approaches to inhibit Bcl-B.

Identifiants

pubmed: 37899453
doi: 10.1186/s13062-023-00431-4
pii: 10.1186/s13062-023-00431-4
pmc: PMC10614328
doi:

Substances chimiques

Proto-Oncogene Proteins c-bcl-2 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Informations de copyright

© 2023. The Author(s).

Références

Hum Mol Genet. 2001 Oct 1;10(21):2329-39
pubmed: 11689480
Cancer Lett. 2017 Jun 1;395:63-71
pubmed: 28259820
J Biomol Struct Dyn. 2023 Mar;41(4):1424-1436
pubmed: 34963406
Leuk Res. 2008 Nov;32(11):1684-97
pubmed: 18339423
Cell Death Differ. 2017 May;24(5):878-888
pubmed: 28362427
Cell Death Dis. 2020 Apr 21;11(4):260
pubmed: 32317622
Cancer Res. 2018 Mar 15;78(6):1404-1417
pubmed: 29330143
Front Genet. 2020 May 13;11:399
pubmed: 32477400
Biochem J. 2003 Nov 15;376(Pt 1):229-36
pubmed: 12921534
Cancer Res. 2004 Feb 15;64(4):1403-10
pubmed: 14973057
Cancer Manag Res. 2021 Sep 01;13:6811-6821
pubmed: 34512021
J Biol Chem. 1998 Dec 4;273(49):32479-86
pubmed: 9829980
Oncogene. 2001 Sep 13;20(41):5846-55
pubmed: 11593390
PLoS One. 2012;7(8):e43180
pubmed: 22905226
J Mol Med (Berl). 2009 Sep;87(9):923-40
pubmed: 19551325
J Biomol Screen. 2008 Aug;13(7):665-73
pubmed: 18626112
Onco Targets Ther. 2018 Nov 09;11:7919-7934
pubmed: 30519035
Biochemistry (Mosc). 2020 Oct;85(10):1235-1244
pubmed: 33202208
Int Rev Cell Mol Biol. 2020;351:23-55
pubmed: 32247581
Cell Death Differ. 2006 Aug;13(8):1419-21
pubmed: 16645636
Genes Dis. 2022 Feb 11;10(1):10-13
pubmed: 37013050
Clin Cancer Res. 2008 May 15;14(10):3011-21
pubmed: 18483366
Aging (Albany NY). 2019 Jan 26;11(2):350-370
pubmed: 30696802
Biol Reprod. 2009 Sep;81(3):497-506
pubmed: 19439730
Reproduction. 2011 May;141(5):549-61
pubmed: 21339285
Mol Cancer Ther. 2008 Jun;7(6):1639-46
pubmed: 18566235
Blood. 2021 Sep 30;138(13):1120-1136
pubmed: 34320168
Nat Rev Cancer. 2016 Feb;16(2):99-109
pubmed: 26822577
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):E119-26
pubmed: 22233804
Exp Mol Med. 2019 Jan 11;51(1):1-13
pubmed: 30635551
J Allergy Clin Immunol. 2014 Apr;133(4):1065-74
pubmed: 24184144
Cell Death Dis. 2012 Dec 13;3:e443
pubmed: 23235460
Biochim Biophys Acta. 2001 Sep 21;1520(3):187-94
pubmed: 11566354
Mol Cell Biol. 2002 Oct;22(19):6866-70
pubmed: 12215543
EMBO J. 2007 May 16;26(10):2527-39
pubmed: 17446862
Exp Dermatol. 2023 Sep 25;:
pubmed: 37750014
Trends Cell Biol. 2019 Jul;29(7):549-562
pubmed: 31030977
Cell Death Dis. 2012 Aug 09;3:e366
pubmed: 22875003
Front Cell Dev Biol. 2018 Feb 13;6:13
pubmed: 29497611
Cancers (Basel). 2020 Dec 30;13(1):
pubmed: 33396645
Theriogenology. 2018 Apr 1;110:1-7
pubmed: 29331495
Hum Reprod. 2013 Mar;28(3):729-39
pubmed: 23293224
Gene Expr Patterns. 2022 Dec;46:119285
pubmed: 36341977
Mol Oncol. 2021 Dec;15(12):3738-3752
pubmed: 34245648
Oncogene. 2013 Sep 12;32(37):4331-42
pubmed: 23085751
Blood. 2007 May 1;109(9):3849-55
pubmed: 17227826
J Biol Chem. 2001 Apr 20;276(16):12481-4
pubmed: 11278245
Proteins. 2010 Jul;78(9):2181-6
pubmed: 20455273
Blood. 2011 Sep 29;118(13):3579-90
pubmed: 21772052
Apoptosis. 2019 Aug;24(7-8):552-561
pubmed: 30911960
FEBS Lett. 2001 Sep 7;505(1):23-6
pubmed: 11557035
Front Oncol. 2023 Jul 31;13:1226289
pubmed: 37601693
Med Oncol. 2018 Sep 11;35(11):145
pubmed: 30206710
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
pubmed: 17717517
Cell. 2005 Sep 23;122(6):927-39
pubmed: 16179260
Cell Death Differ. 2006 Oct;13(10):1631-40
pubmed: 16888646
Oncotarget. 2017 Jul 18;8(29):47103-47109
pubmed: 28514758
Blood. 2014 May 1;123(18):2806-15
pubmed: 24622325
Autophagy. 2012 Apr;8(4):637-49
pubmed: 22498477
J Biomol Struct Dyn. 2010 Dec;28(3):379-91
pubmed: 20919753
Biochem Biophys Res Commun. 2007 Jul 20;359(1):76-82
pubmed: 17532299
Oncogene. 2013 Nov 28;32(48):5439-48
pubmed: 23563182
Cell. 2004 Feb 20;116(4):527-40
pubmed: 14980220
Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):214-219
pubmed: 27260655
J Exp Med. 2016 Aug 22;213(9):1705-22
pubmed: 27455953
Biochem Soc Trans. 2022 Aug 31;50(4):1119-1128
pubmed: 35900226
Cell Cycle. 2016 Dec;15(23):3296-3305
pubmed: 27753540
Oncol Rep. 2010 Jun;23(6):1701-8
pubmed: 20428828
Bioarchitecture. 2011 Sep 1;1(5):216-220
pubmed: 22754611
J Pathol. 2011 Feb;223(3):400-9
pubmed: 21171085
Oncotarget. 2012 Apr;3(4):490-501
pubmed: 22577154
EMBO J. 1999 Jan 4;18(1):167-78
pubmed: 9878060
Pharmacol Res. 2020 Jan;151:104547
pubmed: 31734345
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Mol Hum Reprod. 2017 Aug 1;23(8):549-556
pubmed: 28595284
Explor Target Antitumor Ther. 2022;3(1):11-26
pubmed: 36046354
Elife. 2016 Dec 20;5:
pubmed: 27995898
Biomol Concepts. 2016 Aug 1;7(4):259-70
pubmed: 27505095
J Biol Chem. 2018 Mar 30;293(13):4724-4734
pubmed: 29414782
Biochemistry (Mosc). 2020 Oct;85(10):1210-1226
pubmed: 33202206
Cell Death Dis. 2023 Jul 1;14(6):392
pubmed: 37391438
Assay Drug Dev Technol. 2011 Oct;9(5):465-74
pubmed: 21561376
Histopathology. 2010 Dec;57(6):814-24
pubmed: 21166696
Trends Cancer. 2016 Aug;2(8):443-460
pubmed: 28741496
Leuk Lymphoma. 2014 Jul;55(7):1538-43
pubmed: 24047476
J Biol Chem. 2008 Apr 11;283(15):9580-6
pubmed: 18178565
Int J Cancer. 2006 Oct 1;119(7):1616-22
pubmed: 16671088
Mol Carcinog. 2017 Mar;56(3):1137-1149
pubmed: 27770580
FEBS J. 2015 Mar;282(5):834-849
pubmed: 25559680
Int J Oncol. 2020 Feb;56(2):618-629
pubmed: 31894274

Auteurs

N V Pervushin (NV)

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, 119991, Russia.

G S Kopeina (GS)

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. lirroster@gmail.com.
Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, 119991, Russia. lirroster@gmail.com.

B Zhivotovsky (B)

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. boris.zhivotovsky@ki.se.
Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, 119991, Russia. boris.zhivotovsky@ki.se.
Division of Toxicology, Institute of Environmental Medicine, Karolinska Institute, Box 210, Stockholm, 17177, Sweden. boris.zhivotovsky@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH